Prilenia Therapeutics has signed a partnership and licence agreement with Ferrer to jointly develop and commercialise ...

BrainStorm Cell Therapeutics Inc. , a leading developer of cellular therapies for neurodegenerative diseases, in collaboration with leading ALS research centers, today announced the acceptance of new ...

Biotech Biohaven has signed a non-dilutive funding deal with Oberland Capital as it awaits an FDA ruling on its ...

The United Kingdom (UK) government plans to not grant asylum to people convicted of sex crimes, the UK Home Office website ...

Smith, an ALS patient who lost his ability to speak, has regained communication thanks to Neuralink’s brain implant. Smith is ...